These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23914773)

  • 21. Local (topical and intraocular) therapy for ocular Adamantiades-Behçet's disease.
    Fabiani C; Alió JL
    Curr Opin Ophthalmol; 2015 Nov; 26(6):546-52. PubMed ID: 26367091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic immunosuppressive therapies for uveitis in developing countries.
    Agrawal H; Doan H; Pham B; Khosla A; Babu M; McCluskey P; Nguyen QD; Sangwan V; Reddy S; Sawhney S; Tyagi M
    Indian J Ophthalmol; 2020 Sep; 68(9):1852-1862. PubMed ID: 32823402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of intermediate uveitis].
    Doycheva D; Deuter C; Zierhut M
    Ophthalmologe; 2014 Dec; 111(12):1219-32; quiz 1233-4. PubMed ID: 25448321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiinflammatory medications.
    Leibowitz HM; Kupferman A
    Int Ophthalmol Clin; 1980; 20(3):117-34. PubMed ID: 6998894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical review: Update on treatment of inflammatory macular edema.
    Ossewaarde-van Norel A; Rothova A
    Ocul Immunol Inflamm; 2011 Feb; 19(1):75-83. PubMed ID: 21034302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular corticosteroids for posterior segment disease: 2012 update.
    Kiernan DF; Mieler WF
    Expert Opin Pharmacother; 2012 Aug; 13(12):1679-94. PubMed ID: 22783878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of sight-threatening uveitis: new therapeutic options.
    Becker MD; Smith JR; Max R; Fiehn C
    Drugs; 2005; 65(4):497-519. PubMed ID: 15733012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
    Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):687-698. PubMed ID: 29610003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TNFalpha inhibitors in the treatment of uveitis].
    Greiner K; Plskova J
    Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [News on therapies for uveitis].
    de Smet MD
    J Fr Ophtalmol; 2005 May; 28(5):556-61. PubMed ID: 15976726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
    Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT
    Br J Ophthalmol; 2013 Apr; 97(4):481-6. PubMed ID: 23376607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive therapy for ocular diseases.
    Jap A; Chee SP
    Curr Opin Ophthalmol; 2008 Nov; 19(6):535-40. PubMed ID: 18854699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
    Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
    Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locally administered ocular corticosteroids: benefits and risks.
    McGhee CN; Dean S; Danesh-Meyer H
    Drug Saf; 2002; 25(1):33-55. PubMed ID: 11820911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
    Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
    Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retisert: is the new advance in treatment of uveitis a good one?
    Mohammad DA; Sweet BV; Elner SG
    Ann Pharmacother; 2007 Mar; 41(3):449-54. PubMed ID: 17341531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corticosteroids in ophthalmology].
    Trzcińska-Dabrowska Z
    Pol Tyg Lek; 1972 Jun; 27(26):1008-10. PubMed ID: 4560602
    [No Abstract]   [Full Text] [Related]  

  • 40. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.
    Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J
    J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.